Wednesday, March 16, 2022 12:23:22 PM
Recent BNTX News
- BioNTech to Host Innovation Series R&D Day on November 14, 2024 • GlobeNewswire Inc. • 10/31/2024 11:45:00 AM
- BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 • GlobeNewswire Inc. • 10/21/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/18/2024 01:04:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 09:03:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 12:41:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 08:15:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/10/2024 08:13:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:02:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/08/2024 08:24:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/04/2024 08:17:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/03/2024 09:14:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/02/2024 10:18:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 08:18:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/01/2024 12:12:03 PM
- BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day • GlobeNewswire Inc. • 10/01/2024 10:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/30/2024 08:52:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/27/2024 09:12:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/25/2024 11:14:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/20/2024 01:17:40 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union • Business Wire • 09/20/2024 12:11:00 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union • GlobeNewswire Inc. • 09/20/2024 12:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 11:28:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:14:09 PM
- BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024 • GlobeNewswire Inc. • 09/17/2024 10:45:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:35:58 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM